Capmatinib
CAS-Nr.
1029712-80-8
Englisch Name:
Capmatinib
Synonyma:
INC280;INCB28060;INC28060;2-Fluoro-N-Methyl-4-(7-quinolin-6-ylMethyl-iMidazo[1,2-b][1,2,4] triazin-2-yl)-benzaMide;NC280;CS-192;INCB028060;NVP-INC280;CapMatinib;Karma for,
CBNumber:
CB92574678
Summenformel:
C23H17FN6O
Molgewicht:
412.42
MOL-Datei:
1029712-80-8.mol
Capmatinib Eigenschaften
Schmelzpunkt:
>250°C (dec.)
Dichte
1.40
Dampfdruck
0-0Pa at 20-25℃
storage temp.
-20°C Freezer, Under inert atmosphere
L?slichkeit
DMSO (Slightly), Methanol (Slightly)
pka
13.82±0.46(Predicted)
Aggregatzustand
Solid
Farbe
Pale Yellow to Light Yellow
InChI
InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)
InChIKey
LIOLIMKSCNQPLV-UHFFFAOYSA-N
SMILES
C(NC)(=O)C1=CC=C(C2=NN3C(CC4=CC=C5C(=C4)C=CC=N5)=CN=C3N=C2)C=C1F
LogP
1.6-2.2 at 35℃ and pH7-9
Sicherheit
Risiko- und Sicherheitserkl?rung
Gefahreninformationscode (GHS)
Bildanzeige (GHS)
Alarmwort
Warnung
Gefahrenhinweise
Code
Gefahrenhinweise
Gefahrenklasse
Abteilung
Alarmwort
Symbol
P-Code
H302
Gesundheitssch?dlich bei Verschlucken.
Akute Toxizit?t oral
Kategorie 4
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P270, P301+P312, P330, P501
H315
Verursacht Hautreizungen.
Hautreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P302+P352, P321,P332+P313, P362
H319
Verursacht schwere Augenreizung.
Schwere Augenreizung
Kategorie 2
Warnung
src="/GHS07.jpg" width="20" height="20" />
P264, P280, P305+P351+P338,P337+P313P
H335
Kann die Atemwege reizen.
Spezifische Zielorgan-Toxizit?t (einmalige Exposition)
Kategorie 3 (Atemwegsreizung)
Warnung
src="/GHS07.jpg" width="20" height="20" />
Sicherheit
P261
Einatmen von Staub vermeiden.
P305+P351+P338
BEI KONTAKT MIT DEN AUGEN: Einige Minuten lang behutsam mit Wasser spülen. Eventuell vorhandene Kontaktlinsen nach M?glichkeit entfernen. Weiter spülen.
Capmatinib Chemische Eigenschaften,Einsatz,Produktion Methoden
Beschreibung
Capmatinib is a competitive inhibitor with very potent and selective activity against MET compared to other kinases.
Verwenden
2-Fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide is used in the preparation of a combination formulation with allosteric SHP2 inhibitor TNO155. Used in treatment of non-small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
Trademarks
Tabrecta
Nebenwirkungen
Most common adverse events were nausea, peripheral edema, decreased appetite, rash, and increased amylase and lipase levels.
Capmatinib Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
Capmatinib Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 285)Lieferanten
China 264
India 4
United States 17
Global 285
INCB028060
CapMatinib (INCB28060)
CapMatinib
NC280 BenzaMide,2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-
NVP-INC280
2-Fluoro-N-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide Capmatinib (INCB28060)
INCB28060, INC280
BenzaMide, 2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-
INCB28060
INC28060(BenzaMide, 2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-)
INC 280 (INCB28060)
INCB28060(Capmatinib)
BenzaMide INCB28060
BenzaMide HCl
CAPMATINIB (INCB28060);INCB-28060; INC-280
BenzaMide, 2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-
CS-192
INCB 28060; INCB-28060; INC280
INC280 Capmatinib
CAPMATINIB (INC280)
INCB28060,BenzaMide
NC280
2-fluoro-n-methyl-4-[7-[(quinolin-6-yl)methyl]imidazo[1,2-b]-[1,2,4]triazin-2-yl]benzamide capmatinib
Capmatinib base
2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide
Capmatinib USP/EP/BP
INC28060
INCB28060
2-Fluoro-N-Methyl-4-(7-quinolin-6-ylMethyl-iMidazo[1,2-b][1,2,4] triazin-2-yl)-benzaMide
INC280
Karma for,
Valproic Acid Impurity 69
Capmatinib, 10 mM in DMSO
1029712-80-8
C23H17FN6O
Inhibitors
API